Treatment | Fold of Control | |||
---|---|---|---|---|
2A | 2B4-a | 2E1 | 3A | |
None | 1.00 | 1.00 | 1.00 | 1.00 |
VCH | 3.70 | 2.90 | 2.10 | 1.30 |
ACE | 2.20 | 2.00 | 4.40 | 1.30 |
PB | 4.20 | 4.60 | 0.40 | 1.70 |
DEX | 1.70 | 4.60 | 0.50 | 2.90 |
Western blot analysis (Fig. 4) using microsomes from B6C3F1mice treated with VCH (7.5 mmol/kg/day × 10 days i.p.) or various inducing agents were prepared as described in Materials and Methods. Densitometry was performed and results have been normalized to control (i.e., nontreated mice).
↵4-a Values listed for CYP2B-immunoreactive protein levels do not correspond to the immunoblot in Fig. 4. The data were obtained from a blot in which 10 μg of microsomal protein was loaded (blot not shown), thus allowing for a immunoreactive band to be detected in microsomal fractions isolated from nontreated mice probed with rat CYP2B1.